ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,072.39
-0.84%
Dow Jones
43,988.99
0.59%
Gold vs US Dollar
2,684.245
-0.01%
Brent Oil
73.885
0.00%
Bitcoin
79,749.20
3.87%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Avidity Biosciences Inc (RNA) Share Price

RNA Avidity Biosciences Inc

46.72
-0.79 (-1.66%)
09 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Avidity Biosciences Inc NASDAQ:RNA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.79 -1.66 46.72 44.00 50.00 47.295 44.85 46.76 1,075,534 01:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 9.56M -212.22M -1.7951 -26.02 5.62B
 Type  Size  Price  Time  Units 
 9 1 44.88 00:47:40 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore RNA News
07/11/202421:09EDGAR2Form 8-K - Current report
07/11/202421:05PRNUSAvidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
31/10/202413:00PRNUSAvidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024
30/10/202412:01EDGAR2Form 8-K - Current report
30/10/202412:00PRNUSAvidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy
21/10/202420:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/10/202420:20EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
14/02/201112:15PBBHow SLN stands against its RNA-therapy competitors - an objective review121
29/10/200909:49PBBMDRNA2
Data Downloads for RNA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Avidity Biosciences Inc Articles